Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126193111 | 12619311 | 1 | I | 2014 | 20160727 | 20160803 | 20160803 | EXP | US-AMGEN-USASP2016097911 | AMGEN | 51.00 | YR | A | M | Y | 0.00000 | 20160803 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126193111 | 12619311 | 1 | PS | EPOGEN | ERYTHROPOIETIN | 1 | Unknown | 40000 UNIT, QMO | U | 103234 | UNKNOWN FORMULATION | /month | |||||||
| 126193111 | 12619311 | 2 | SS | EPOGEN | ERYTHROPOIETIN | 1 | Unknown | 40000 UNIT, EVERY 2 TO 3 MONTHS | U | 103234 | UNKNOWN FORMULATION | ||||||||
| 126193111 | 12619311 | 3 | SS | EPOGEN | ERYTHROPOIETIN | 1 | Unknown | UNK | U | 103234 | UNKNOWN FORMULATION | ||||||||
| 126193111 | 12619311 | 4 | SS | ARANESP | DARBEPOETIN ALFA | 1 | Unknown | 30 MUG, QWK | 0 | 30 | UG | SOLUTION FOR INJECTION | /wk | ||||||
| 126193111 | 12619311 | 5 | SS | ARANESP | DARBEPOETIN ALFA | 1 | Unknown | 60 MUG, 2 TIMES/WK | 0 | 60 | UG | SOLUTION FOR INJECTION | BIW | ||||||
| 126193111 | 12619311 | 6 | C | TRADJENTA | LINAGLIPTIN | 1 | 5 MG, QD | 0 | 5 | MG | QD | ||||||||
| 126193111 | 12619311 | 7 | C | LEVEMIR | INSULIN DETEMIR | 1 | 14 UNIT, QD | 0 | QD | ||||||||||
| 126193111 | 12619311 | 8 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 75 MG, QD | 0 | 75 | MG | QD | ||||||||
| 126193111 | 12619311 | 9 | C | COREG | CARVEDILOL | 1 | 12.5 MG, QD | 0 | 12.5 | MG | QD | ||||||||
| 126193111 | 12619311 | 10 | C | ASA | ASPIRIN | 1 | 325 UNK, QD | 0 | QD | ||||||||||
| 126193111 | 12619311 | 11 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 50 MG, QD | 0 | 50 | MG | QD | ||||||||
| 126193111 | 12619311 | 12 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | 60 MG, QD | 0 | 60 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126193111 | 12619311 | 1 | Chronic kidney disease |
| 126193111 | 12619311 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126193111 | 12619311 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126193111 | 12619311 | Asthenia | |
| 126193111 | 12619311 | Coronary artery bypass | |
| 126193111 | 12619311 | Fatigue | |
| 126193111 | 12619311 | Muscle tightness | |
| 126193111 | 12619311 | Myalgia | |
| 126193111 | 12619311 | Pain | |
| 126193111 | 12619311 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126193111 | 12619311 | 1 | 201101 | 0 | ||
| 126193111 | 12619311 | 2 | 201511 | 0 | ||
| 126193111 | 12619311 | 3 | 201605 | 0 | ||
| 126193111 | 12619311 | 4 | 201511 | 0 | ||
| 126193111 | 12619311 | 5 | 201605 | 0 |